Abstract
The adenosine modulation system is mostly composed by inhibitory A1 receptors (A1R) and the less abundant facilitatory A2A receptors (A2AR), the latter selectively engaged at high frequency stimulation associated with synaptic plasticity processes in the hippocampus. A2AR are activated by adenosine originated from extracellular ATP through ecto-5’-nucleotidase or CD73-mediated catabolism. Using hippocampal synaptosomes, we now investigated how adenosine receptors modulate the synaptic release of ATP. The A2AR agonist CGS21680 (10-100 nM) enhanced the K+-evoked release of ATP, whereas both SCH58261 and the CD73 inhibitor α,β-methylene ADP (100 μM) decreased ATP release; all these effects were abolished in forebrain A2AR knockout mice. The A1R agonist CPA (10-100 nM) inhibited ATP release, whereas the A1R antagonist DPCPX (100 nM) was devoid of effects. The presence of SCH58261 potentiated CPA-mediated ATP release and uncovered a facilitatory effect of DPCPX. Overall, these findings indicate that ATP release is predominantly controlled by A2AR, which are involved in an apparent feedback loop of A2AR-mediated increased ATP release together with dampening of A1R-mediated inhibition. This study is a tribute to María Teresa Miras-Portugal.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
ATP is a multifactorial signaling molecule in the brain, involved in the communication between glia cells as well as in the bidirectional communication between glia and neurons (reviewed in [1]). Extracellular ATP is also produced upon synaptic activity in accordance with the accumulation of ATP in synaptic vesicles and its release with different neurotransmitters (e.g. [2, 3]), namely in the hippocampus [4,5,6], a brain region where synaptic plasticity processes are proposed to encode reference memory traits [7]. Although hippocampal synapses are endowed with different ATP-activated P2 receptors (e.g. [8]), the most evident role of extracellular ATP is to be a substrate for the action of ecto-nucleotidases, regulated by ecto-5’-nucleotidase or CD73 [9], to form extracellular adenosine to selectively activate adenosine A2A receptors (A2AR) [10,11,12]. A2AR are selectively engaged to control synaptic plasticity processes [13,14,15,16,17] and control memory and neurodegeneration (reviewed in [18]).
The adenosine neuromodulation system is a classical neuromodulation system, with a powerful inhibitory effect operated by A1R and a selective recruitment of A2AR to control synaptic plasticity [18], which involve a discrete facilitation of neurotransmitter release [19,20,21], the attenuation of the predominant A1R-mediated inhibition [19, 22, 23] and a post-synaptic facilitation of NMDA receptor-mediated responses [14, 24]. Since ATP release selectively occurs at high frequency simulation [4, 25] and selectively feeds A2AR to control synaptic plasticity processes, we now explored if A2AR control of ATP release from nerve terminals is a putative feedback loop involving CD73-mediated formation of adenosine from released ATP to activate A2AR-mediated facilitation of ATP release, as occurs for astrocytic ATP release [26]. Furthermore, we also aimed at understanding if ATP release is affected by the A1R-mediated inhibitory system, which robustly inhibits the release of classical neurotransmitters.
Methods
Animals
We used 32 male and female mice (20.8±0.2 g, 8-10 weeks old) from our inbred colony of forebrain A2A receptor knockout mice with a C57BL/6 genetic background [11] and wild type C57BL/6 obtained from Charles River (Barcelona, Spain). Mice were housed in collective cages with an enriched environment in HEPA-filtered ventilated racks (n=3-5 per cage) under a controlled environment (12 h light-dark cycle, lights on at 7 AM, and room temperature 22±1°C) with ad libitum access to food and water. The study was approved by the Ethical Committee of the Center for Neuroscience and Cell Biology (ORBEA n° 138-2016/15072016), following European Union guidelines (2010/63).
Preparation of synaptosomes
In spite of their artificial nature, difficulties in experimentally triggering neurotransmitter release with a ‘physiological’ pattern and their heterogeneity, synaptosomes are still the most adequate preparation to unambiguously ascribe mechanisms as occurring presynaptically [27]. Hippocampal synaptosomes (purified synapses) were prepared as previously described [28]. After deep anesthesia under halothane atmosphere, each mouse was decapitated, the two hippocampi were dissected and homogenized in sucrose (0.32 M) solution containing 1 mM EDTA, 10 mM HEPES, 1 mg/mL bovine serum albumin (Sigma), pH 7.4 at 4 °C, supplemented with a protease inhibitor, phenylmethylsulfonyl fluoride (PMSF 0.1 mM), a cocktail of inhibitors of proteases (CLAP 1%, Sigma) and the antioxidant dithiothreitol (1 μM). The homogenate was centrifuged at 3,000 x g for 10 min at 4 °C and the resulting supernatant was further centrifuged at 14,000 x g for 12 min at 4 °C. The resulting pellet (P2 fraction) was resuspended in 1 mL of a 45% (v/v) Percoll solution in Krebs-HEPES buffer (140 mM NaCl, 5 mM KCl, 25 mM HEPES, 1 mM EDTA, 10 mM glucose; pH 7.4). After centrifugation at 14,000 x g for 2 min at 4 °C, the white top layer was collected (synaptosomal fraction), resuspended in 1 mL Krebs-HEPES buffer and further centrifuged at 14,000 x g for 2 min at 4 °C. The pellet was then resuspended in Krebs-HEPES solution. The purity of this synaptic fraction has been previously quantified as >95% [28].
ATP release
The release of ATP was measured on-line using the luciferin-luciferase assay, as previously described [11]. Briefly, a suspension containing synaptosomes, an ATP assay mix (with luciferin and luciferase; from Sigma) and Krebs-HEPES solution was equilibrated at 25 °C during 10 min to ensure the functional recovery of nerve terminals. The suspension was then transferred to a white 96-well plate and measurements were performed in a luminometer (Victor3). After 60 seconds to measure basal ATP outflow, the evoked release of ATP was triggered with 32 mM of KCl (isomolar substitution of NaCl in the Krebs-HEPES solution), a well-established neurochemical strategy to trigger optimal signal-to-noise calcium-dependent vesicular release from synaptosomes without damage to these artificial synaptic structures [27]. The evoked release of ATP was calculated by integration of the area of the peak upon subtraction of the estimated basal ATP outflow [11].
Pharmacological manipulations
We used the A2AR agonist 2-[4-(2-p-carboxyethyl)phenylamino]-5’-N-ethylcarboxamidoadenosine (CGS21680, Tocris) in a selective concentration range (10-100 nM; [29]), the A2AR antagonist 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4 triazolo[1,5-c]pyrimidine (SCH58261; Tocris) at a supra-maximal but selective concentration (50 nM; [14]), the selective A1R agonist N6-cyclopentyladenosine (CPA, Tocris) in a selective concentration range (10-100 nM; [30]), the A1R antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, Tocris) at a supra-maximal but selective concentration (100 nM [30]) and the ecto-5’-nucleotidase or CD73 inhibitor α,β-methylene ADP (AOPCP, Sigma-Aldrich) at a supra-maximal but selective concentration (100 μM [11]). AOPCP was directly prepared in Krebs solution, whereas all adenosine receptor ligands were prepared as 5 mM stock solutions in dimethylsulfoxide.
Statistics
The values are presented as mean±S.E.M. The percentage effect of drugs was calculated in each individual experiment and the S.E.M. is relative to the variance of this percentage effect. To test the significance of the effect of drugs versus control, a paired Student’s t test was used. When making comparisons from a different set of experiments with control, a one-way analysis of variance (ANOVA) was used, followed by a Dunnett’s test. P < 0.05 was considered to represent a significant difference.
Results
A2A receptors increase the evoked release of ATP
The K+-induced release of ATP from nerve terminals likely reflects a vesicular release of ATP [2, 5, 31, 32], as now confirmed by the dependency of this evoked ATP release on the presence of extracellular free calcium. Thus, the elevation of extracellular K+ to 30 mM to depolarize synaptosomes triggered a release of ATP (Fig. 1A, black line); the average K+-evoked ATP release was 21.9±2.3 pmol/mg protein (n=6). This K+-induced release of ATP was reduced by over 90% in a Krebs medium without added calcium (n=4; Fig. 1A, grey line).
Since the activation of A2AR facilitates the release of different classical neurotransmitters from hippocampal nerve terminals [19, 21, 33], we now tested if A2AR activation also facilitated the release of ATP. The A2AR agonist CGS21680 increased the evoked release of ATP and this facilitation was larger (p=0.044) at 30 nM CGS21680 (40.1±8.0% facilitation, n=6) than at 10 nM (15.7±2.3%, n=4) and saturated at 100 nM (30.4±4.1%, n=5) (Fig. 1B). The selective A2AR antagonist SCH58261 (50 nM) decreased the evoked release of ATP by 41.7±4.5% (n=6), indicating that endogenous adenosine tonically activates A2AR to bolster ATP release (Fig. 1B). Furthermore, CGS21680 (30 nM) was devoid of effects (p=0.391; n=4) in the presence of 50 nM SCH58261 (Fig. 1B), further confirming the involvement of A2AR in the control of ATP release from hippocampal synaptosomes. Importantly, neither CGS21680 (10-100 nM) nor SCH58261 (50 nM) modified the basal outflow of ATP in the absence of K+-induced depolarization (data not shown).
CD73-mediated ATP-derived adenosine feeds A2A receptors to control ATP release
Since A2AR are selectively activated by CD73-mediated extracellular ATP-derived adenosine [10,11,12, 32, 34], we probed if CD73 was involved in a putative feedback facilitating loop of ATP release from nerve terminals, as previously observed for ATP release from astrocytes [26]. Thus, we tested the impact of the CD73 inhibitor AOPCP on the evoked release of ATP from hippocampal nerve terminals. As shown in Fig. 1C, AOPCP (100 μM) inhibited the K+-evoked release of ATP by 20.3±2.7% (n=6) in hippocampal synaptosomes from wild type mice, where AOPCP was devoid of effects (p=0.351; n=4) in hippocampal synaptosomes from A2AR knockout mice (Fig. 1C) and did not modify the basal outflow of ATP in the absence of K+-induced depolarization in wild type or A2AR knockout mice (data not shown). Moreover, the evoked release of ATP from hippocampal synaptosomes from A2AR knockout mice was not modified by either 30 nM CGS21680 (p=0.947; n=4) or 50 nM SCH58261 (p=0.653; n=4) (Fig. 1C), further reenforcing a putative feedback modulation role of A2AR in bolstering ATP release as a consequence of extracellular ATP-derived adenosine formation.
A2A receptors dampen A1 receptor-mediated inhibition of ATP release
The concluded robust effect of A2AR in the control of ATP release is somewhat surprising in view of the discrete impact of A2AR in the control of different classical neurotransmitters from hippocampal nerve terminals, such as glutamate [19], GABA [33] or acetylcholine [21]. Since A2AR control A1R-mediated effects in nerve terminals [19, 22, 23], we next investigated the impact of A1R on ATP release and the effect of A2AR on this putative A1R-mediated modulation of ATP release.
As shown in Fig. 2A, the selective A1R agonist CPA decreased the evoked release of ATP in a concentration-dependent manner, with inhibitions of 8.5±2.0% at 10 nM (n=4), 17.8±3.6% at 30 nM (n=4) and 26.1±4.4% at 100 nM (n=4). In the presence of the selective A1R antagonist DPCPX (100 nM), CPA (30 nM) was devoid of effects on the evoked release of ATP (p=0.077; n=4), confirming the involvement of A1R in the inhibitory effect of CPA on ATP release (Fig. 2A). Notably, DPCPX (100 nM) did not significantly modify the evoked release of ATP (p=0.622; n=4), indicating that endogenous adenosine does not tonically activate A1R to inhibit ATP release (Fig. 2A). Neither CPA (10-100 nM) nor DPCPX (100 nM) modified the basal outflow of ATP in the absence of K+-induced depolarization (data not shown).
To test if A2AR controlled A1R-mediated inhibition of ATP release, we next tested the ability of A1R to modulate ATP release upon blockade of A2AR. In the presence of 50 nM SCH58261, CPA at lower concentrations triggered a more robust inhibition of the evoked release of ATP, which was 20.1±2.2% at 10 nM (n=4; p=0.008 vs. the effect of 10 nM CPA in the absence of SCH58261), 31.3±2.3% at 30 nM (n=4; p=0.020 vs. the effect of 30 nM CPA in the absence of SCH58261) and 36.4±7.7% at 100 nM (n=4; p=0.267 vs. the effect of 100 nM CPA in the absence of SCH58261) (Fig. 2B). This more robust effect of CPA in the presence of SCH58261 only involved A1R activation since CPA (30 nM) was devoid of effects in the presence of 100 nM DPCPX (p=0.622; n=4) (Fig. 2B). Importantly, in the presence of SCH58261, DPCPX (100 nM) increased the evoked release of ATP by 17.7±2.7% (n=4), indicating that A2AR are dampening the ability of A1R to inhibit ATP release from hippocampal synaptosomes (Fig. 2B).
Discussion
The present study shows that the release of ATP from nerve terminals is controlled in a dual and opposite manner by adenosine inhibitory A1 receptors (A1R) and facilitatory A2A receptors (A2AR). The release of ATP from nerve terminals was mainly controlled by A2AR, which activation caused a robust increase of ATP with an efficacy far superior to that controlling other classical neurotransmitters such as glutamate [19, 20, 35], GABA [33, 36] or acetylcholine [21, 27, 37, 38]. Moreover, A2AR blockade revealed a tonic activation of A2AR bolstering the release of ATP, which was not observed when studying the evoked release of classical neurotransmitter [38,39,40]. In contrast, whereas A1R activation triggers a robust inhibition of the release of classical neurotransmitters such as glutamate [19, 20, 41] and acetylcholine [28, 39, 42, 43], A1R agonists caused a comparatively lower inhibition of the evoked release of ATP. Furthermore, whereas there is a constant A1R tonic inhibition by endogenous extracellular adenosine of the evoked release of glutamate [15, 30, 44] or acetylcholine [28, 39, 42, 43], the A1R antagonist DPCPX was devoid of effects on the evoked release of ATP from hippocampal nerve terminals, in contrast to the reported A1R-mediated inhibition of ATP release from superior cervical ganglion [45] or in cultures enriched in cholinergic amacrine-like neurons [46]. This suggests a different relative organization of A1R and A2AR to control the presynaptic release of ATP and of classical neurotransmitters in different neuronal circuits (c.f. [15, 17, 47]).
A striking particularity of the modulation by adenosine of the evoked release of ATP from hippocampal nerve terminals is the control of A1R-mediated inhibition by A2AR. In fact, we observed that the blockade of A2AR augmented the ability of A1R to inhibit ATP release, which indicates that A2AR curtails A1R function. The mechanism underlying this ability of A2AR to control A1R function may either involve the eventual release of an intermediate soluble messenger or a direct interaction between A2AR-A1R heteromers [35]. Indeed, previous neurochemical studies showed that A2AR and A1R are located in the same individual hippocampal nerve terminal [48] and that A2AR activation decreases A1R binding in hippocampal synaptosomes [22, 23]. This translates into an ability of A2AR to shut down inhibitory A1R to allow the implementation of synaptic plasticity, which would otherwise be impeded by the over-activation of A1R upon increased extracellular purine release at higher frequencies of nerve stimulation [4, 25]. This ability of A2AR to control A1R is further illustrated by the dependency of A2AR-mediated facilitation of glutamatergic transmission on an on-going A1R-mediated inhibition, as observed in the hippocampus [19] or in the visual [49] or neocortex [50]. Importantly, although we now observed that A2AR curtailed A1R function, the ability of A2AR to enhance synaptic ATP release is not dependent on A1R since A2AR enhanced ATP release and A1R blockade was devoid of effects. Altogether, these findings indicate that the adenosine modulation of the evoked release of ATP from hippocampal nerve terminals seems to be different from the control of the evoked release of classical neurotransmitters such as glutamate or acetylcholine: thus, the release of ATP from hippocampal nerve terminals is predominantly controlled by A2AR rather than A1R, as also previously reported for the control of neuronal ATP release in the retina [51] and ATP currents in the habenula [52].
The presently reported different modulation by adenosine of the presynaptic release of ATP and of classical neurotransmitters joins previous observations of a different calcium channel dependence [46, 53], different requirements of intensity/frequency of stimulation [4, 25] and a temporal and pharmacological dissociation of the release of ATP from the release of classical neurotransmitters in different preparations [5, 54,55,56,57,58,59]. Given the observed calcium sensitivity of the presynaptic release of ATP and previous reports that this presynaptic ATP release is vesicular in nature [2, 5, 31, 32], it remains to be determined if the presynaptic release of ATP and of classical neurotransmitter occurs from different nerve terminals (see [41]) or from different vesicles within the same nerve terminal (see [5]), as hinted by the peculiar distribution of vesicular nucleoside transporters in different synaptic vesicles [6]. Furthermore, it cannot be excluded that part of the presynaptic release of ATP might be non-vesicular, given that there are several proposed mechanisms for ATP release in different preparations [60,61,62]. Clearly, the mechanism of ATP release from nerve terminals remains to be adequately characterized to better understand the mechanistic basis of the observed different modulation by adenosine of the release of ATP and of classical neurotransmitters.
The presently observed ability of A2AR to bolster ATP release and the conclusion that the activation of A2AR depends on CD73-mediated ATP-derived adenosine indicates the existence of a putative feedback facilitatory loop in synapses linking ATP release/CD73 activity/A2AR activation. This neuronal ATP release/CD73/A2AR activation loop is qualitatively similar to that present in astrocytes [26] but has a different physiological meaning. In fact, the astrocytic ATP release/CD73/A2AR activation loop is expected to sustain a paracrine ATPergic activation of the astrocytic network (reviewed in [63]) in parallel with an adenosinergic inhibition (A1R-mediated) of synaptic transmission [64, 65], which contributes to implement a process of heterosynaptic depression (see [66, 67]). In contrast, the neuronal ATP release/CD73/A2AR activation loop is proposed to be an autocrine adenosinergic potentiation (A2AR-mediated) of glutamate release restricted to the ‘activated’ synapse responsible for the A2AR-mediated control of synaptic plasticity [13,14,15,16,17, 24, 68], which is selectively dependent on CD73-mediated formation of ATP-derived extracellular adenosine [11, 12, 14, 16, 32]. These different conclusions should not be viewed as antagonic but rather complementary, contributing to the implementation of salience of information encoding [69] by bolstering the activity of an ‘activated’ synapse and simultaneously decreasing the activity of surrounding synapses. This illustrates the numerous intertwined roles of the purinergic modulation system in different brain compartments [1], which further stresses the need to study the spatiotemporal gradients of extracellular ATP and adenosine in relation to the different adenosine receptors to better grasp the physiopathological roles of adenosine. This complexity is further increased by the need to recognize that apart being a substrate to ecto-nucleotidases generating adenosine, extracellular ATP also exerts direct roles as a neurotransmitter and neuromodulator [70, 71] through numerous post-synaptic and presynaptic P2X and P2Y receptors [8, 72], as championed by the group of María Teresa Miras-Portugal (e.g. [73, 74]). Importantly, it should be kept in mind that this proposed feedback facilitatory loop linking A2AR activation and an increased ATP release to sustain A2AR activation was so far only documented in purified synaptosomes and it remains to be confirmed if a similar mechanism is present in more integrated brain preparations, namely in an in vivo situation. Furthermore, future studies should investigate the possible contribution of this proposed feedback facilitatory loop to the synaptic dysfunction characteristic of different neuropsychiatric diseases, in view of the previously reported up-regulation of synaptic A2AR in numerous brain diseases (e.g. [11, 12, 18, 24, 68], as well as the established role of released ATP as a danger signal in the brain [71].
Data Availability
The data are available from the corresponding author upon reasonable request.
References
Agostinho P, Madeira D, Dias L, Simões AP, Cunha RA, Canas PM (2020) Purinergic signaling orchestrating neuron-glia communication. Pharmacol Res 162:105253. https://doi.org/10.1016/j.phrs.2020.105253
Richardson PJ, Brown SJ (1987) ATP release from affinity-purified rat cholinergic nerve terminals. J Neurochem 48:622–630. https://doi.org/10.1111/j.1471-4159.1987.tb04138.x
Jo YH, Role LW (2002) Coordinate release of ATP and GABA at in vitro synapses of lateral hypothalamic neurons. J Neurosci 22:4794–4804. https://doi.org/10.1523/JNEUROSCI.22-12-04794.2002
Cunha RA, Vizi ES, Ribeiro JA, Sebastião AM (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 67:2180–2187. https://doi.org/10.1046/j.1471-4159.1996.67052180.x
Pankratov Y, Lalo U, Verkhratsky A, North RA (2006) Vesicular release of ATP at central synapses. Pflugers Arch 452:589–597. https://doi.org/10.1007/s00424-006-0061-x
Larsson M, Sawada K, Morland C, Hiasa M, Ormel L, Moriyama Y, Gundersen V (2012) Functional and anatomical identification of a vesicular transporter mediating neuronal ATP release. Cereb Cortex 22:1203–1214. https://doi.org/10.1093/cercor/bhr203
Martin SJ, Grimwood PD, Morris RG (2000) Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 23:649–711. https://doi.org/10.1146/annurev.neuro.23.1.649
Rodrigues RJ, Almeida T, Richardson PJ, Oliveira CR, Cunha RA (2005) Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J Neurosci 25:6286–6295. https://doi.org/10.1523/JNEUROSCI.0628-05.2005
Cunha RA (2001) Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 26:979–991. https://doi.org/10.1023/a:1012392719601
Carmo M, Gonçalves FQ, Canas PM, Oses JP, Fernandes FD, Duarte FV, Palmeira CM, Tomé AR, Agostinho P, Andrade GM, Cunha RA (2019) Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson's disease. Br J Pharmacol 176:3666–3680. https://doi.org/10.1111/bph.14771
Gonçalves FQ, Lopes JP, Silva HB, Lemos C, Silva AC, Gonçalves N, Tomé ÂR, Ferreira SG, Canas PM, Rial D, Agostinho P, Cunha RA (2019) Synaptic and memory dysfunction in a β-amyloid model of early Alzheimer's disease depends on increased formation of ATP-derived extracellular adenosine. Neurobiol Dis 132:104570. https://doi.org/10.1016/j.nbd.2019.104570
Augusto E, Gonçalves FQ, Real JE, Silva HB, Pochmann D, Silva TS, Matos M, Gonçalves N, Tomé ÂR, Chen JF, Canas PM, Cunha RA (2021) Increased ATP release and CD73-mediated adenosine A2A receptor activation mediate convulsion-associated neuronal damage and hippocampal dysfunction. Neurobiol Dis 157:105441. https://doi.org/10.1016/j.nbd.2021.105441
d'Alcantara P, Ledent C, Swillens S, Schiffmann SN (2001) Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission. Neuroscience 107:455–464. https://doi.org/10.1016/s0306-4522(01)00372-4
Rebola N, Lujan R, Cunha RA, Mulle C (2008) Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 57:121–134. https://doi.org/10.1016/j.neuron.2007.11.023
Costenla AR, Diógenes MJ, Canas PM, Rodrigues RJ, Nogueira C, Maroco J, Agostinho PM, Ribeiro JA, Cunha RA, de Mendonça A (2011) Enhanced role of adenosine A2A receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur J Neurosci 34:12–21. https://doi.org/10.1111/j.1460-9568.2011.07719.x
Simões AP, Gonçalves FQ, Rial D, Ferreira SG, Lopes JP, Canas PM, Cunha RA (2022) CD73-mediated formation of extracellular adenosine is responsible for adenosine A2A receptor-mediated control of fear memory and amygdala plasticity. Int J Mol Sci 23:12826. https://doi.org/10.3390/ijms232112826
Kerkhofs A, Canas PM, Timmerman AJ, Heistek TS, Real JI, Xavier C, Cunha RA, Mansvelder HD, Ferreira SG (2018) Adenosine A2A receptors control glutamatergic synaptic plasticity in fast spiking interneurons of the prefrontal cortex. Front Pharmacol 9:133. https://doi.org/10.3389/fphar.2018.00133
Cunha RA (2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139:1019–1055. https://doi.org/10.1111/jnc.13724
Lopes LV, Cunha RA, Kull B, Fredholm BB, Ribeiro JA (2002) Adenosine A2A receptor facilitation of hippocampal synaptic transmission is dependent on tonic A1 receptor inhibition. Neuroscience 112:319–329. https://doi.org/10.1016/s0306-4522(02)00080-5
Marchi M, Raiteri L, Risso F, Vallarino A, Bonfanti A, Monopoli A, Ongini E, Raiteri M (2002) Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol 136:434–440. https://doi.org/10.1038/sj.bjp.0704712
Rebola N, Oliveira CR, Cunha RA (2002) Transducing system operated by adenosine A2A receptors to facilitate acetylcholine release in the rat hippocampus. Eur J Pharmacol 454:31–38. https://doi.org/10.1016/s0014-2999(02)02475-5
Lopes LV, Cunha RA, Ribeiro JA (1999a) Cross talk between A1 and A2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82:3196–3203. https://doi.org/10.1152/jn.1999.82.6.3196
Lopes LV, Cunha RA, Ribeiro JA (1999) ZM 241385, an adenosine A2A receptor antagonist, inhibits hippocampal A1 receptor responses. Eur J Pharmacol 383:395–398. https://doi.org/10.1016/s0014-2999(99)00659-7
Temido-Ferreira M, Ferreira DG, Batalha VL, Marques-Morgado I, Coelho JE, Pereira P, Gomes R, Pinto A, Carvalho S, Canas PM, Cuvelier L, Buée-Scherrer V, Faivre E, Baqi Y, Müller CE, Pimentel J, Schiffmann SN, Buée L, Bader M et al (2020) Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Mol Psychiatry 25:1876–1900. https://doi.org/10.1038/s41380-018-0110-9
Wieraszko A, Goldsmith G, Seyfried TN (1989) Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 485:244–250. https://doi.org/10.1016/0006-8993(89)90567-2
Madeira D, Dias L, Santos P, Cunha RA, Canas PM, Agostinho P (2021) Association between adenosine A2A receptors and connexin 43 regulates hemichannels activity and ATP release in astrocytes exposed to amyloid-β peptides. Mol Neurobiol 58:6232–6248. https://doi.org/10.1007/s12035-021-02538-z
Raiteri L, Raiteri M (2000) Synaptosomes still viable after 25 years of superfusion. Neurochem Res 25:1265–1274. https://doi.org/10.1023/a:1007648229795
Rodrigues RJ, Canas PM, Lopes LV, Oliveira CR, Cunha RA (2008) Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol Aging 29:1597–1601. https://doi.org/10.1016/j.neurobiolaging.2007.03.025
Cunha RA, Constantino MD, Ribeiro JA (1997) ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br J Pharmacol 122:1279–1284. https://doi.org/10.1038/sj.bjp.0701507
Sebastião AM, Cunha RA, de Mendonça A, Ribeiro JA (2000) Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats. Br J Pharmacol 131:1629–1634. https://doi.org/10.1038/sj.bjp.0703736
White TD, MacDonald WF (1990) Neural release of ATP and adenosine. Ann N Y Acad Sci 603:287–298. https://doi.org/10.1111/j.1749-6632.1990.tb37680.x
Gonçalves FQ, Matheus FC, Silva HB, Real JI, Rial D, Rodrigues RJ, Oses JP, Silva AC, Gonçalves N, Prediger RD, Tomé AR, Cunha RA (2023) Increased ATP release and higher impact of adenosine A2A receptors on corticostriatal plasticity in a rat model of presymptomatic Parkinson’s disease. Mol Neurobiol 60:1659–1674. https://doi.org/10.1007/s12035-022-03162-1
Cunha RA, Ribeiro JA (2000) Purinergic modulation of [3H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 39:1156–1167. https://doi.org/10.1016/s0028-3908(99)00237-3
Augusto E, Matos M, Sévigny J, El-Tayeb A, Bynoe MS, Müller CE, Cunha RA, Chen JF (2013) Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. J Neurosci 33:11390–11399. https://doi.org/10.1523/JNEUROSCI.5817-12.2013
Ciruela F, Casadó V, Rodrigues RJ, Luján R, Burgueño J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortés A, Canela EI, López-Giménez JF, Milligan G, Lluis C, Cunha RA, Ferré S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080–2087. https://doi.org/10.1523/JNEUROSCI.3574-05.2006
Morales-Figueroa GE, Márquez-Gómez R, González-Pantoja R, Escamilla-Sánchez J, Arias-Montaño JA (2014) Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes. ACS Chem Neurosci 5:637–645. https://doi.org/10.1021/cn500001m
Kirk IP, Richardson PJ (1994) Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release. J Neurochem 62:960–966. https://doi.org/10.1046/j.1471-4159.1994.62030960.x
Jin S, Fredholm BB (1997) Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release. Naunyn Schmiedebergs Arch Pharmacol 355:48–56. https://doi.org/10.1007/pl00004917
Cunha RA, Milusheva E, Vizi ES, Ribeiro JA, Sebastião AM (1994) Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 63:207–214. https://doi.org/10.1046/j.1471-4159.1994.63010207.x
Shindou T, Nonaka H, Richardson PJ, Mori A, Kase H, Ichimura M (2002) Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus. Br J Pharmacol 136:296–302. https://doi.org/10.1038/sj.bjp.0704702
Thompson SM, Haas HL, Gähwiler BH (1992) Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol 451:347–363. https://doi.org/10.1113/jphysiol.1992.sp019168
Jackisch R, Strittmatter H, Kasakov L, Hertting G (1984) Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol 327:319–325. https://doi.org/10.1007/BF00506243
Sperlágh B, Zsilla G, Baranyi M, Kékes-Szabó A, Vizi ES (1997) Age-dependent changes of presynaptic neuromodulation via A1-adenosine receptors in rat hippocampal slices. Int J Dev Neurosci 15:739–747. https://doi.org/10.1016/s0736-5748(97)00028-2
Dunwiddie TV (1980) Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21:541–548. https://doi.org/10.1111/j.1528-1157.1980.tb04305.x
Vizi ES, Liang SD, Sperlágh B, Kittel A, Jurányi Z (1997) Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 79:893–903. https://doi.org/10.1016/s0306-4522(96)00658-6
Santos PF, Caramelo OL, Carvalho AP, Duarte CB (1999) Characterization of ATP release from cultures enriched in cholinergic amacrine-like neurons. J Neurobiol 41:340–348
Martin-Fernandez M, Jamison S, Robin LM, Zhao Z, Martin ED, Aguilar J, Benneyworth MA, Marsicano G, Araque A (2017) Synapse-specific astrocyte gating of amygdala-related behavior. Nat Neurosci 20:1540–1548. https://doi.org/10.1038/nn.4649
Rebola N, Rodrigues RJ, Lopes LV, Richardson PJ, Oliveira CR, Cunha RA (2005) Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus. Neuroscience 133:79–83. https://doi.org/10.1016/j.neuroscience.2005.01.054
Bannon NM, Zhang P, Ilin V, Chistiakova M, Volgushev M (2014) Modulation of synaptic transmission by adenosine in layer 2/3 of the rat visual cortex in vitro. Neuroscience 260:171–184. https://doi.org/10.1016/j.neuroscience.2013.12.018
Zhang P, Bannon NM, Ilin V, Volgushev M, Chistiakova M (2015) Adenosine effects on inhibitory synaptic transmission and excitation-inhibition balance in the rat neocortex. J Physiol 593:825–841. https://doi.org/10.1113/jphysiol.2014.279901
Newman EA (2004) A dialogue between glia and neurons in the retina: modulation of neuronal excitability. Neuron Glia Biol 1:245–252. https://doi.org/10.1017/S1740925X0500013X
Robertson SJ, Edwards FA (1998) ATP and glutamate are released from separate neurones in the rat medial habenula nucleus: frequency dependence and adenosine-mediated inhibition of release. J Physiol 508:691–701. https://doi.org/10.1111/j.1469-7793.1998.691bp.x
Magalhães-Cardoso MT, Pereira MF, Oliveira L, Ribeiro JA, Cunha RA, Correia-de-Sá P (2003) Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings. J Physiol 549:399–408. https://doi.org/10.1113/jphysiol.2003.040410
Rabasseda X, Solsona C, Marsal J, Egea G, Bizzini B (1987) ATP release from pure cholinergic synaptosomes is not blocked by tetanus toxin. FEBS Lett 213:337–340. https://doi.org/10.1016/0014-5793(87)81518-1
Trachte GJ, Binder SB, Peach MJ (1989) Indirect evidence for separate vesicular neuronal origins of norepinephrine and ATP in the rabbit vas deferens. Eur J Pharmacol 164:425–433. https://doi.org/10.1016/0014-2999(89)90250-1
Ellis JL, Burnstock G (1990) Modulation by prostaglandin E2 of ATP and noradrenaline co-transmission in the guinea-pig vas deferens. J Auton Pharmacol 10:363–372. https://doi.org/10.1111/j.1474-8673.1990.tb00036.x
Fariñas I, Solsona C, Marsal J (1992) Omega-conotoxin differentially blocks acetylcholine and adenosine triphosphate releases from Torpedo synaptosomes. Neuroscience 47:641–648. https://doi.org/10.1016/0306-4522(92)90172-x
Gonçalves J, Bültmann R, Driessen B (1996) Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 353:184–192. https://doi.org/10.1007/BF00168756
Todorov LD, Mihaylova-Todorova S, Craviso GL, Bjur RA, Westfall DP (1996) Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens. J Physiol 496:731–748. https://doi.org/10.1113/jphysiol.1996.sp021723
Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26:959–969. https://doi.org/10.1023/a:1012388618693
Corriden R, Insel PA (2010) Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal 3:re1. https://doi.org/10.1126/scisignal.3104re1
Li A, Banerjee J, Leung CT, Peterson-Yantorno K, Stamer WD, Civan MM (2011) Mechanisms of ATP release, the enabling step in purinergic dynamics. Cell Physiol Biochem 28:1135–1144. https://doi.org/10.1159/000335865
Koizumi S (2010) Synchronization of Ca2+ oscillations: involvement of ATP release in astrocytes. FEBS J 277:286–292. https://doi.org/10.1111/j.1742-4658.2009.07438.x
Fujii S, Tanaka KF, Ikenaka K, Yamazaki Y (2014) Increased adenosine levels in mice expressing mutant glial fibrillary acidic protein in astrocytes result in failure of induction of LTP reversal (depotentiation) in hippocampal CA1 neurons. Brain Res 1578:1–13. https://doi.org/10.1016/j.brainres.2014.07.005
Tan Z, Liu Y, Xi W, Lou HF, Zhu L, Guo Z, Mei L, Duan S (2017) Glia-derived ATP inversely regulates excitability of pyramidal and CCK-positive neurons. Nat Commun 8:13772. https://doi.org/10.1038/ncomms13772
Chen J, Tan Z, Zeng L, Zhang X, He Y, Gao W, Wu X, Li Y, Bu B, Wang W, Duan S (2013) Heterosynaptic long-term depression mediated by ATP released from astrocytes. Glia 61:178–191. https://doi.org/10.1002/glia.22425
Chasse R, Malyshev A, Fitch RH, Volgushev M (2021) Altered heterosynaptic plasticity impairs visual discrimination learning in adenosine A1 receptor knock-out mice. J Neurosci 41:4631–4640. https://doi.org/10.1523/JNEUROSCI.3073-20.2021
Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, Hamdane M, Humez S, Müller CE, Lopes LV et al (2016) A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry 21:97–107. https://doi.org/10.1038/mp.2014.151
Cunha RA (2008) Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochem Int 52:65–72. https://doi.org/10.1016/j.neuint.2007.06.026
Cunha RA, Ribeiro JA (2000) ATP as a presynaptic modulator. Life Sci 68:119–137. https://doi.org/10.1016/s0024-3205(00)00923-1
Rodrigues RJ, Tomé AR, Cunha RA (2015) ATP as a multi-target danger signal in the brain. Front Neurosci 9:148. https://doi.org/10.3389/fnins.2015.00148
Rubio ME, Soto F (2001) Distinct localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci 21:641–653. https://doi.org/10.1523/JNEUROSCI.21-02-00641.2001
Díaz-Hernández M, Gómez-Villafuertes R, Hernando F, Pintor J, Miras-Portugal MT (2001) Presence of different ATP receptors on rat midbrain single synaptic terminals. Involvement of the P2X3 subunits. Neurosci Lett 301:159–162. https://doi.org/10.1016/s0304-3940(01)01614-7
Hervás C, Pérez-Sen R, Miras-Portugal MT (2005) Presence of diverse functional P2X receptors in rat cerebellar synaptic terminals. Biochem Pharmacol 70:770–785. https://doi.org/10.1016/j.bcp.2005.05.033
Funding
Open access funding provided by FCT|FCCN (b-on). This project was funded by LaCaixa Foundation (LCF/PR/HP17/52190001), FCT (UIDB/04539/2020), and ERDF through Centro 2020 (project CENTRO-01-0145-FEDER-000008:BrainHealth 2020 and CENTRO-01-0246-FEDER-000010).
Author information
Authors and Affiliations
Contributions
FQG, PV, MM and ART carried out the experiments and analyzed the data; ART and RAC supervised the project and wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
RAC is a scientific consultant for the Institute for Scientific Information on Coffee. All other authors declare no conflict of interests.
Ethical approval
Animal experiments were approved by the Ethical Committee of the Center for Neuroscience and Cell Biology (ORBEA 138-2016/1507201) and followed the European Union guidelines (2010/63).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gonçalves, F.Q., Valada, P., Matos, M. et al. Feedback facilitation by adenosine A2A receptors of ATP release from mouse hippocampal nerve terminals. Purinergic Signalling 20, 247–255 (2024). https://doi.org/10.1007/s11302-023-09937-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-023-09937-y